citalopram has been researched along with Weight Loss in 5 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
Weight Loss: Decrease in existing BODY WEIGHT.
Excerpt | Relevance | Reference |
---|---|---|
" To compare changes in body weight during treatment with different antidepressants, body weight and height were measured at baseline and after 6, 8, 12 and 26 wk treatment with escitalopram or nortriptyline in 630 adults with moderate-to-severe unipolar depression participating in GENDEP, a part-randomized open-label study." | 5.15 | Changes in body weight during pharmacological treatment of depression. ( Aitchison, KJ; Dernovsek, MZ; Farmer, A; Gray, JM; Hauser, J; Henigsberg, N; Kalember, P; Keers, R; Kozel, D; Larsen, ER; Maier, W; McGuffin, P; Mendlewicz, J; Mors, O; Placentino, A; Rietschel, M; Souery, D; Strohmaier, J; Szczepankiewicz, A; Uher, R; Zobel, A, 2011) |
"Citalopram is a new, highly selective inhibitor of 5HT re-uptake." | 2.67 | Treatment of severe obesity with a highly selective serotonin re-uptake inhibitor as a supplement to a low calorie diet. ( Elsborg, L; Szkudlarek, J, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boston, CD | 1 |
Wolter, H | 1 |
Schneider, N | 1 |
Pfeiffer, E | 1 |
Lehmkuhl, U | 1 |
Uher, R | 1 |
Mors, O | 1 |
Hauser, J | 1 |
Rietschel, M | 1 |
Maier, W | 1 |
Kozel, D | 1 |
Henigsberg, N | 1 |
Souery, D | 1 |
Placentino, A | 1 |
Keers, R | 1 |
Gray, JM | 1 |
Dernovsek, MZ | 1 |
Strohmaier, J | 1 |
Larsen, ER | 1 |
Zobel, A | 1 |
Szczepankiewicz, A | 1 |
Kalember, P | 1 |
Mendlewicz, J | 1 |
Aitchison, KJ | 1 |
McGuffin, P | 1 |
Farmer, A | 1 |
Szkudlarek, J | 1 |
Elsborg, L | 1 |
Bergh, C | 1 |
Eriksson, M | 1 |
Lindberg, G | 1 |
Södersten, P | 1 |
2 trials available for citalopram and Weight Loss
Article | Year |
---|---|
Changes in body weight during pharmacological treatment of depression.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Body Mass Index; Body Weight; Citalopram; Depressive | 2011 |
Treatment of severe obesity with a highly selective serotonin re-uptake inhibitor as a supplement to a low calorie diet.
Topics: Adolescent; Adult; Aged; Citalopram; Combined Modality Therapy; Diet, Reducing; Double-Blind Method; | 1993 |
3 other studies available for citalopram and Weight Loss
Article | Year |
---|---|
Competitive EDge or over the cliff?
Topics: Antidepressive Agents, Second-Generation; Citalopram; Depression; Fatigue; Humans; Hypercalcemia; Ma | 2013 |
Diagnostic crossover from obesity to atypical anorexia nervosa - a case report.
Topics: Adolescent; Amenorrhea; Anorexia Nervosa; Antidepressive Agents, Second-Generation; Behavior Therapy | 2009 |
Selective serotonin reuptake inhibitors in anorexia.
Topics: Adolescent; Adult; Anorexia Nervosa; Antidepressive Agents; Child; Citalopram; Combined Modality The | 1996 |